Research Papers

25 of 1103 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical settin…
Damiana TST; Paraïso P; de Ridder C; Stuurman D; Seimbille Y; Dalm SU.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing …
Barry N; Francis RJ; Ebert MA; Koh ES; Rowshanfarzad P; Hassan GM; Kendrick J; Gan HK; Lee ST; Lau E; Moffat BA; Fitt G; Moore A; Thomas P; Pattison DA; Akhurst T; Alipour R; Thomas EL; Hsiao E; Schembri GP; Lin P; Ly T; Yap J; Kirkwood I; Vallat W; Khan S; Krishna D; Ngai S; Yu C; Beuzeville S; Yeow TC; Bailey D; Cook O; Whitehead A; Dykyj R; Rossi A; Grose A; Scott AM.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
EANM procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine.
Camoni L; Santos A; Luporsi M; Grilo A; Pietrzak A; Gear J; Zucchetta P; Bar-Sever Z.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Error mitigation enables PET radiomic cancer characterization on quantum computers.
Moradi S; Spielvogel C; Krajnc D; Brandner C; Hillmich S; Wille R; Traub-Weidinger T; Li X; Hacker M; Drexler W; Papp L.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.
Albert NL; Nelwan DV; Fleischmann DF; Quach S; von Rohr K; Kaiser L; Teske N; Unterrainer LM; Bartos LM; Ruf VC; Brendel M; Riemenschneider MJ; Wetzel C; Herms J; Rupprecht R; Thon N; Tonn JC; Belka C; Bartenstein P; von Baumgarten L; Niyazi M; Unterrainer M; Holzgreve A.
J Nucl Med (Unknown)
Published: 2023
2/6 Transparent
18 F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy.
Feng Y; Wang P; Chen Y; Dai W.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Feasibility of [<sup>18</sup>F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective f…
Islam S; Inglese M; Grech-Sollars M; Aravind P; Dubash S; Barwick TD; O'Neill K; Wang J; Saleem A; O'Callaghan J; Anchini G; Williams M; Waldman A; Aboagye EO.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors.
Chahid Y; Hashimi K; van de Garde EMW; Klümpen HJ; Hendrikse NH; Booij J; Verberne HJ.
Clin Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Early biochemical and radiographic response after one cycle of [<sup>177</sup>Lu]Lu-PSMA I&T radioligand therapy in met…
Cytawa W; Hendel R; Tomasik B; Weinzierl FX; Bley T; Jassem J; Schirbel A; Buck AK; Bundschuh RA; Hartrampf PE; Werner RA; Lapa C.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Sol…
Gondry O; Xavier C; Raes L; Heemskerk J; Devoogdt N; Everaert H; Breckpot K; Lecocq Q; Decoster L; Fontaine C; Schallier D; Aspeslagh S; Vaneycken I; Raes G; Van Ginderachter JA; Lahoutte T; Caveliers V; Keyaerts M.
J Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Radiofrequency ablation for autonomously functioning nodules as treatment for hyperthyroidism: subgroup analysis of tox…
van der Meeren MMD; Joosten FBM; Roerink SHPP; Deden LN; Oyen WJG.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
2/6 Transparent
Quantitation of dynamic total-body PET imaging: recent developments and future perspectives.
Gu F; Wu Q.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison of 99mTc radiolabeled somatostatin antagonist with [<sup>68</sup> Ga]Ga-DOTA-TATE in a patient with advanced…
Opalinska M; Lezaic L; Decristoforo C; Kolenc P; Mikolajczak R; Studen A; Simoncic U; Virgolini I; Trofimiuk-Muldner M; Garnuszek P; Rangger C; Fani M; Glowa B; Skorkiewicz K; Hubalewska-Dydejczyk A.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Molecular Imaging, Radiochemistry, and Environmental Pollutants.
Delaney S; Sebastiano J; Zeglis BM; Keinänen OM.
J Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Incremental prognostic value of stress phase entropy over standard PET myocardial perfusion imaging variables.
Kuronuma K; Miller RJH; Van Kriekinge SD; Han D; Singh A; Gransar H; Dey D; Berman DS; Slomka PJ.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Urinary excretion kinetics of [<sup>177</sup>Lu]Lu-PSMA-617.
de Bakker M; Dominicus N; Meeuwis A; Janssen M; Konijnenberg MW; Nagarajah J; Peters SMB.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Registered
Analysis of radioactivity in commercially available products aiming to improve health and wellness.
Thomas R; Forssell-Aronsson E; Hjellström M; Insulander Björk K; Piñero-García F; Isaksson M.
Radiat Prot Dosimetry (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
The EANM guideline on radioiodine therapy of benign thyroid disease.
Campennì A; Avram AM; Verburg FA; Iakovou I; Hänscheid H; de Keizer B; Petranović Ovčariček P; Giovanella L.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
1/6 Transparent
The study of virtual source position with the geometric convergent ratio errors prevention management method of spot sc…
Zhang WH; Luo BZ; Ye YC; Wu JM.
Radiat Prot Dosimetry (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with <sup>223</sup>Ra: PARABO, a…
Palmedo H; Ahmadzadehfar H; Eschmann S; Niesen A; Schönberger J; Barsegian V; Liepe K; Mottaghy FM; Guan R; Pinkert J; Sandström P; Herrmann K.
J Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
How to combine CTA, <sup>99m</sup>Tc-WBC SPECT/CT, and [<sup>18</sup>F]FDG PET/CT in patients with suspected abdominal …
Lauri C; Campagna G; Aloisi F; Posa A; Iezzi R; Sirignano P; Taurino M; Signore A.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The radioecological footprint of electricity production by wind turbines.
Bittner S; Gellermann R; Walther C.
Radiat Prot Dosimetry (Unknown)
Published: 2023
2/6 Transparent
Data
Prospective Comparison of the Imaging Value of 99m Tc-MDP Bone Scan and 68 Ga-FAPI-04 PET/CT in Synovitis, Acne, Pustul…
Xu T; Ding H; Fan D; Shu Q; Liu G; Zhang S; Chen Y.
Clin Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Patient exposure during videofluoroscopic swallowing studies performed by speech-language pathologists.
Tsalafoutas IA; AlKhazzam S; Hussain MS; Omar AJ; Bawazir SS; AlHamad SA; AlNaemi H; Kharita MH.
Radiat Prot Dosimetry (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry.
Kovan B; Demir B; Işık EG; Has Şimşek D; Özkan ZG; Kuyumcu S; Türkmen C; Şanlı Y.
Radiat Prot Dosimetry (Unknown)
Published: 2023
2/6 Transparent